SALT LAKE CITY, Dec. 22, 2010 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that Peter D. Meldrum, President and CEO, is scheduled to present at the 29th Annual J.P. Morgan Healthcare Conference, at 4:00 p.m. Pacific on January 12, 2011, at the Westin St. Francis Hotel in San Francisco, California.
